(Q34130552)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Saaristo A

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Karpanen T

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

6122-6129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Isolation of a tumor factor responsible for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Induction of angiogenesis during the transition from hyperplasia to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Hypoxia and the regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Openings between defective endothelial cells explain tumor vessel leakiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Antiangiogenis restricted tumor dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Proteolytic processing regulates receptor specificity and activity of VEGF-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Tumor targeting with a selective gelatinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Angiopoietins 3 and 4: diverging gene counterparts in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

A cancer therapy resistant to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

Chemotherapy targeted to tumor vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Angiogenesis as a marker of preneoplastic lesions of the human breast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Basement Membrane Collagen: Degradation by Migrating Endothelial Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Neuropilin-1 is a placenta growth factor-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Vascular gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203969

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11156525%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 November 2019

1034156048

0 references

1 reference